NCT00239109View on ClinicalTrials.gov

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

February 28, 2007

Conditions
Schizophrenia
Interventions
DRUG

Ziprasidone

DRUG

Olanzapine

PROCEDURE

Scales

PROCEDURE

measures of the body (Weight...)

PROCEDURE

Serum analysis

Trial Locations (7)

Unknown

Pfizer Investigational Site, Bilbao

Pfizer Investigational Site, Badajoz

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Madrid

Pfizer Investigational Site, Salamanca

Pfizer Investigational Site, Seville

Pfizer Investigational Site, Zamora

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00239109 - Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. | Biotech Hunter | Biotech Hunter